These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1204275)

  • 21. Interaction between metronidazole and drugs eliminated by oxidative metabolism.
    Jensen JC; Gugler R
    Clin Pharmacol Ther; 1985 Apr; 37(4):407-10. PubMed ID: 3979002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of amiodarone and desethylamiodarone on the pharmacokinetics of antipyrine in the rat.
    Svensson CK; Liu LL; Knowlton PW
    Pharm Res; 1987 Jun; 4(3):251-4. PubMed ID: 3509291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
    Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of disposition parameters of quinidine and quinine in the rat.
    Watari N; Wakamatsu A; Kaneniwa N
    J Pharmacobiodyn; 1989 Oct; 12(10):608-15. PubMed ID: 2630631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the immunomodulator tilorone on antipyrine disposition in the rat.
    Svensson CK
    J Pharm Sci; 1986 Oct; 75(10):946-8. PubMed ID: 3795024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dose size on the pharmacokinetics of orally administered quinine.
    Sowunmi A; Salako LA
    Eur J Clin Pharmacol; 1996; 49(5):383-6. PubMed ID: 8866633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age, sex, and nitrazepam kinetics: relation to antipyrine disposition.
    Greenblatt DJ; Abernethy DR; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1985 Dec; 38(6):697-703. PubMed ID: 4064471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
    Albanus L; Jönsson M; Sparf B
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):63-9. PubMed ID: 300543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ibuprofen does not impair antipyrine clearance.
    Abernethy DR; Greenblatt DJ
    J Clin Pharmacol; 1983; 23(11-12):517-22. PubMed ID: 6662976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
    Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the half-life of antipyrine in plasma, whole blood and saliva of man.
    van Boxtel CJ; Wilson JT; Lindgren S; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Feb; 9(4):327-32. PubMed ID: 971716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):98-106. PubMed ID: 8004366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.
    Denlinger CL; Stryker KK; Slusher LB; Vesell ES
    Clin Pharmacol Ther; 1987 May; 41(5):522-30. PubMed ID: 3568537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S58-66. PubMed ID: 8793604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1977 Sep; 22(3):259-68. PubMed ID: 891094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
    Kappas A; Anderson KE; Conney AH; Alvares AP
    Clin Pharmacol Ther; 1976 Dec; 20(6):643-53. PubMed ID: 991535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.